Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

FINASTERIDE 5 MG

FINASTERIDE : 5 MG · DIN 02350270 · PRO DOC LIMITEE

Health Canada status: MARKETED

What is FINASTERIDE?

FINASTERIDE 5 MG contains FINASTERIDE : 5 MG. It is listed in the Health Canada Drug Product Database under DIN 02350270, held by PRO DOC LIMITEE, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 07-May-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is FINASTERIDE used for?

FINASTERIDE (finasteride) is a Type II 5 α-reductase inhibitor, indicated as monotherapy for the treatment and control of benign prostatic hyperplasia (BPH) and for the prevention of urologic events to: Reduce the risk of acute urinary retention; Reduce the risk of surgery including transurethral resection of the prostate (TURP) and prostatectomy. FINASTERIDE causes regression of the enlarged prostate, improves urinary flow and improves the symptoms associated with BPH.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02350270
Brand nameFINASTERIDE
Generic / active ingredientFINASTERIDE : 5 MG
ManufacturerPRO DOC LIMITEE
Strength5 MG
Dosage formTABLET
Route of administrationORAL
SchedulePrescription
ATC codeG04CB01 FINASTERIDE
AHFS class92:04.00
BiosimilarNo
Health Canada statusMARKETED
Status date07-May-2026
Original market date2010-04-29 00:00:00

How is it stored and handled?

Store at temperature between 15°C - 30°C and protect from light.

How is it supplied?

blister packages of 30 tablets and bottle of 30 and 100 tablets.

What can be used instead?

Other Canadian products sharing ATC code G04CB01 FINASTERIDE. 12 of 25 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
ACH-FINASTERIDE5 MGTABLETACCORD HEALTHCARE INCMARKETEDDIN 02355043
AURO-FINASTERIDE5 MGTABLETAURO PHARMA INCMARKETEDDIN 02405814
BIO-FINASTERIDE5 MGTABLETBIOMED PHARMAMARKETEDDIN 02527847
FINASTERIDE5 MGTABLETSIVEM PHARMACEUTICALS ULCMARKETEDDIN 02447541
FINASTERIDE5 MGTABLETSANIS HEALTH INCMARKETEDDIN 02445077
MINT-FINASTERIDE5 MGTABLETMINT PHARMACEUTICALS INCMARKETEDDIN 02389878
NRA-FINASTERIDE5 MGTABLETNORA PHARMA INCMARKETEDDIN 02535637
PMS-FINASTERIDE5 MGTABLETPHARMASCIENCE INCMARKETEDDIN 02310112
PROSCAR5 MGTABLETORGANON CANADA INC.MARKETEDDIN 02010909
RIVA-FINASTERIDE5 MGTABLETLABORATOIRE RIVA INC.MARKETEDDIN 02455013

Who else supplies FINASTERIDE worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. FINASTERIDE appears in 305 registered pack listings across 15 markets, published on 12 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for FINASTERIDE

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for FINASTERIDE

Health Canada Drug Product Database (DPD), DIN 02350270. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.